Page last updated: 2024-08-24

gemcitabine and 1-palmitoyl-2-oleoylphosphatidylcholine

gemcitabine has been researched along with 1-palmitoyl-2-oleoylphosphatidylcholine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambre, AH; Borowicz, PP; Guo, B; Haldar, MK; Katti, KS; Katti, P; Kulkarni, PS; Mallik, S; Muhonen, WW; Nahire, RR; Padi, SK; Reindl, K; Shabb, JB; Shrivastava, DK; Singh, RK1

Other Studies

1 other study(ies) available for gemcitabine and 1-palmitoyl-2-oleoylphosphatidylcholine

ArticleYear
Mmp-9 responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancer.
    Molecular pharmaceutics, 2014, Jul-07, Volume: 11, Issue:7

    Topics: Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Drug Carriers; Drug Delivery Systems; Extracellular Matrix; Female; Gemcitabine; Glutathione; Humans; Hydrolysis; Lipid Bilayers; Lipopeptides; Matrix Metalloproteinase 9; Mice; Mice, Nude; Nanoparticles; Pancreatic Neoplasms; Phosphatidylcholines; Polyethylene Glycols; Transport Vesicles

2014